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After  allograft  rejection  in  mice  specifically cytotoxic  lymphoid  cells  can 
be detected throughout  the lymphoid apparatus with the notable exception of 
the  thymus (1).  This apparent lack of involvement of thymocytes from suit- 
ably immunized  animals at  the  effector level of cell-mediated immunity may 
seem surprising, for thymocytes have been shown to undergo blast transforma- 
tion in vitro in the presence of foreign lymphoid cells (2, 3), and certain actively 
cytotoxic cells have been shown both  to bear the  thymus-specific antigen  (4) 
and to be derived from the thynms (5). 
The present  study confirms earlier findings  that  thymocytes from immune 
animals are not cytotoxic in vitro to specific allogeneic target cells when cells 
from  the  spleen  and  lymph  nodes  are.  However,  we found  that  thymocytes 
from  such  immune  animals  may  cooperate  with  other  nonimmune  cells  in 
vitro  causing  specific  cytotoxic  effects on  target  cells.  Cytotoxic  activity  of 
the  cooperating cells was measured in  a  system previously used  to assay the 
direct cytotoxic activity of spleen cells sensitized in vivo to the murine lymph- 
oma LS178Y (6). Earlier studies have reported a synergistic cytotoxic effect on 
target  lymphoma  cells  by  immune  lymphoid  cells  and  nonimmune  macro- 
phages (7,  8), and it may be that the present investigation represents another 
aspect of such cell interactions. 
Cooperation between thymus-derived cells and  bone-marrow cells has been 
extensively studied  and  is  thought  to  be necessary for the  initiation  of  both 
some humoral  (9)  and  cell-mediated  (10,  11)  immune responses.  This  report 
describes cooperation between specifically immune thymocytes and other cells 
to effect a  synergistic cytotoxic reaction in vitro. A  distinction must be made 
between the modes of cell cooperation involving thymic cells that occur at the 
afferent and  the efferent arms of the immune response. 
Materials and 34ethods 
Animals.--Specific pathogen-free mice of inbred C57BL strain  were obtained from our 
own breeding colonies. The experimental animals used were of either sex and between 10 and 
14 wk of age. 
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Tumors,--The  L5178Y  lymphoma  obtained  from  Dr.  Fischer  (Yale  University, New 
Haven,  Conn.)  is  of  thymic origin,  syngeneic in  DBA/2  mice.  TLX5  (CBA)  and  TLX9 
(C57BL)  lymphomas were induced in these laboratories by X-rays and benzpyrene, respec- 
tively; the August rat leukemia is spontaneous and myeloblastic. These tumors have all been 
maintained by serial passage in adult syngeneic animals and regular returns to early passages 
preserved in a tumor bank have been made. 
Immunization  of Lymphoid Cell Donors.--C57BL  mice were immunized intraperitoneally 
with,a single dose of  107  live L5178Y  lymphoma cells.  In  tests for specificity, 107  TLX5 
lymphoma cells  or August leukemia cells  or 0.1  ml of heparinized whole sheep blood was 
substituted. 
Preparation of  Cell Suspensions.--Spleens,  thymuses,  and  femurs  were  removed from 
groups of five mice and pooled cell suspensions prepared by squeezing the excised organs with 
forceps in tissue culture medium 199  (TC  199).  1 Bone-marrow cells were obtained by syring- 
ing the marrow cavities of mouse femurs. To remove the thymuses, lateral incisions were 
made from diaphragm to clavicle and the resultant flap of rib cage was deflected back. Care 
was taken to avoid removal of the parathymic lymph nodes. 
Culture of LS178Y Lymphoma and Lymphoid Cells.--At  weekly intervals, lymphoma cells 
from the peritoneal cavity of DBA/2 mice were removed and washed twice in TC  199. The 
cells were maintained in culture for a period of 1 wk in Fischer's medium (obtained in pow- 
dered form from Grand Island Biological  Co., Grand Island, N. Y.) supplemented with 10% 
fetal calf serum (FCS)  (Flow Laboratories, Irvine, Scotland). Before use this serum was heat 
inactivated at 56°C for 90 rain. The cells were routinely grown for 24 hr in vitro before use in 
growth-inhibition tests.  McCartney bottles  (capacity  15  ml)  fitted  with  silicone  rubber 
stoppers were used as culture vessels. L5178Y  cells grow logarithmically as single unattached 
cells with a doubling time of 12-16 hr to a maximum of 8 X  105 cells/ml. To 1.5 )< 105 L5178Y 
cells were added 3.0  X  107 lymphoid cells (previously mixed at a ratio of one thymocyte to 
one bone-marrow or spleen cell). The final volume was 3.3 ml and to avoid nutrient depletion 
in the medium, an equal volume of fresh medium was added at each 24 hr interval during the 
experiment. 
The  method  used  for  determining the  cytotoxic effect in  mixtures  of  lymphoid  and 
lymphoma ceils has been described (6). Growth inhibition was expressed as the percentage of 
surviving cells in test cultures compared to the number of cells  in control cultures after a 
72  hr period. 
Irradiation of Cell Cultures.--Cell  suspensions were prepared and  diluted  to  5  X  107 
cells/ml with Fischer's medium at 5°C  immediately before irradiation with 220  kv X-rays 
given at 800 R/rain. 
Assay for  Toxicity by  Chromium Release.--Following Wigzell  (12),  L5178Y  cells  from 
cultures were incubated at 37°C  with 51Cr (as  sodium chromate in saline from the Radio- 
chemical Centre, Amersham, England) at 25  ~Ci/ml for 30  rain. Mter washing twice, the 
labeled lymphoma cells were resuspended at 2.0 X  105 cells/ml and 4  X  107 lymphoid cells 
were added. At intervals thereafter 1-ml aliqnots were diluted to 3.0  ml with medium 199 
and centrifuged at 2000 rpm for 3 rain.  1.0-ml samples of supernatant fluid were counted in a 
Packard gamma counter, Packard Instrument Co.,  Downers Grove, IlL  Total  release was 
found by freeze-thawing samples three times, spinning, and counting the supernatant. 
Stim,dation  of Nudeic  Acid  Synthesis in  Immune  Thymocytes.--Thymocytes  (2  X  10 a 
cells/ml)  were cultured  with  104  target cells/ml in  Fischer's medium.  At  intervals  1-ml 
aliquots of culture were taken and pulsed with uridine-3H or thymidine-3H (Radiochemical 
Centre) at 5/zCi/ml for 60 rain.  The cells were poured onto filter paper, washed thoroughly 
with phosphate-buffered  saline and with ice-cold 5% trichloroacetic acid, rinsed with ethanol 
and  acetone,  and  the  activity  counted in  a  Packard  Tri-Carb  scintillation counter.  The 
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results were expressed  as: 
count/106 thymocytes from immune mice 
Per cent increase in  incorporation  =  100 X 
count/106 tbymocytes from nonimmune mice 
Preparation of Thymus Supernatant.--l.O  X  10  r thymocytes/ml were incubated for 24 or 
48  hr in Fischer's medium containing 1.0  X  106 lymphoma cells/ml (irradiated  with 5000 
R  of X-rays  24 hr previously).  The supernatant  was  separated  by centrffugation  at  2000 
rpm,  filtered  through  a  sterile  0.45  #  Millipore filter  (Millipore  Corp.,  Bedford,  Mass.), 
and stored at --20°C. For assay 1.5 ml of supernatant was added to 1.5 X  10 r bone-marrow 
cells/flask. 
A ntisera.-- 
Rabbit anti-mouse-'y-globulin serum:  Serum globulins from old breeding mice were precipi- 
tated twice with 50% ammonium sulfate, dissolved in saline,  and injected intravenously into 
rabbits three times at 14-day  intervals; venous sera were obtained I0 days later from the ear 
and were tested for activity by immunodiffusion against normal mouse serum.  The serum was 
adsorbed  with LS178Y cells.  Activity was detected against IgM but was predominantly  to 
IgG. 
Rabbit anti-mouse macrophage serum:  DBA/2 peritoneal macrophage cultures were grown 
for 24 hr in dishes coated with collagen following Ehrmann and Gey (13). Lymphocytes were 
removed by washing and  viable macrophages were obtained  by treating the cultures with 
0.1% collagenase (Sigma Chemical Co., St. Louis, Mo.)  for 20 rain.  5  X  106 macrophages 
were injected intravenously at  10-day  intervals and  the sera obtained  14 days later.  After 
adsorption the serum was tested in the presence of 3% complement on peritoneal macrophage 
cultures, spleen cells, and thymocytes. Cell death was deternfined after a 30 min incubation 
at 37°C and lysis of 100, 11, and 2% were found, respectively. 
All sera (except FCS) were adsorbed on washed L5178Y cells at 4°C for 1 hr at a  ratio of 
1 vol packed cells: 2 vols serum. After centrifugation the sera were filtered through a sterile 
0.45/z Millipore. Sera were then heat inactivated at 56°C for 45 min. 
Glass Bead Treatment of Cell Suspensions.--Cell  suspensions  containing 2  X  107 cells/ml 
were placed in 30-ml tissue culture flasks  (Falcon Plastics, Los Angeles,  Calif.)  containing 
sterile glass beads  (4.5-5.5  mm diameter Hopkins and Williams Ltd., Essex, England).  The 
flasks were incubated for 24 hr with periodic gentle agitation to ensure maximum cell surface 
and glass contact. The supernatant was removed and the flasks gently washed with TC 199. 
The cells  were concentrated  by centrifugation,  counted  using  trypan  blue,  and  then  used. 
RESULTS 
Specific  Growth Inhibition  by  Thymus  Cells from Immune Mice in  Presence 
of Normal  Bone-Marrow  or Spleen  Cells.--The  growth  of  L5178Y  lymphoma 
cells (strain of origin DBA/2  mice) in vitro was inhibited in an immunologically 
specific manner  by  spleen  cells (6)  and  bone-marrow  cells but  not  by  thymo- 
cytes  from  C57BL  mice  that  had  been  immunized  21  days  previously  with 
L5178Y  cells.  Bone-marrow  and  spleen  ceils  from  nonimmune  C57BL  mice 
did  not  affect  the  growth  of  the L5178Y  cells and  under  the  conditions  used 
there was no evidence for allogeneic inhibition  (6,  14). However, as can be seen 
from Table I, thymocytes from immunized  mice  exerted  a  cytotoxic  effect on 
L5178Y  lymphoma  when  nonimmune  bone-marrow  or  spleen  cells  were  also 
added. 
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from  mice  immune  to  DBA/2  lymphoma  with  nonimmune  spleen  or  bone- 
marrow cells was tested for specificity by two methods. The cell mixture was 
cultured with the C57BL  mouse lymphoma referred to as TLX9.  The growth 
of TLX9  cells was  unaffected  under  conditions when  the  growth  of L5178Y 
lymphoma cells was inhibited by 80%.  Alternatively, C57BL  mice were  im- 
munized with 0.1  ml of sheep blood,  or 107 leukemia cells from a  transplanted 
CBA mouse lymphoma (referred to as TLXS), or 107  August rat leukemia cells. 
The  growth  inhibitory activity of the  thymocytes was  then  tested  with  and 
without bone marrow cells.  These  results  are  summarized  in  Table  II. 
TABLE  I 
Effect of C57BL  Lymphoid  Cells and Cell Mixtures  on the Growth of L5178Y  Cells In  Vitro 
Cell suspensions* prepared from  Per cent growth inhibition  4- s~ at: 
Nonimmune mice  Irnnrnune~ mice  48 hr  72 hr 
Spleen  None  8  4- 4  I0  4- 3 
None  Spleen  91  4- 4  97  4- 3 
Bone marrow  None  6  4-  4  5  4-  4 
None  Bone marrow  77  4-  5  95  4-  3 
Thymus  None  3  4-  2  4  4-  3 
None  Thymus  4  4- 4  4  4-  6 
Cell mixtures§:thymus +  bone  6  4-  2  7  4-  1 
marrow 
Bone marrow  Thymus  61  4-  11  80  4-  8 
Thymus +  spleen  7  4- 3  9  4- 4 
Spleen  Thymus  56  4- 4  68  4-  7 
* Total cell to lymphoma ratio 200:1. 
:~ C57BL mice immunized 21 days previously with 107 live LS178Y cells i.p. 
§ Ratio of thymus cells to bone marrow or spleen cells 1:1. 
To study the effects of varying the ratio of the two cell populations which 
cooperate in the cytotoxic  reaction,  the  ratio  of  "immune"  thymocytes  to 
lymphoma  cells  was  varied  from  25:1  to  100:1.  Nutrient  fluctuations  in 
the  culture  medium  due  to  differing  cell  concentrations  were  avoided  by 
maintaining  the  total  number  of  cells  in  the  system  constant  by  adding 
nonimmune  thymocytes.  Table  III  shows  that  the  cytotoxic effect  became 
greater as the concentration of immune  thymocytes was  increased.  Variation 
of  the  bone-marrow  cell  concentration  outside  the  range  shown  was  not 
possible,  as  these  cells were  found  to  be metabolically very  active,  the  use 
of  high  numbers  resulted  in  nutrient  depletion to  an  extent  that  would  not 
support lymphoma cell growth. 
Changes  in  the  Thymus  after  Immunization  with  the  Allogeneic  Lymphoma 
Cells.--In a previous study (6) two populations of cytotoxic lymphocytes were 
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most  striking being resistance to radiation. The  radioresistant cytotoxic cells 
appeared within 6  days after immunization but  were not detected at periods 
longer than  14  days, whereas  the population  of radiosensitive cytotoxic cells 
built up slowly in the spleen with maximum activity between  14 and 21  days 
TABLE  II 
The Specificity  of the Synergistic  Cytotoxic Reaction 
Thymus cells from C57BL  Immunizing dose  Target cell*  Per cent  growth 
mice immunized with  in vitro  inhibition at 
72 hr 
L5178Y  1  X  107  cells  L5178Y  80  ±  8 
TLX9  7 ~  6 
Sheep red blood cells  0.1ml of heparinized whole  LS178Y  9  :i= 4 
blood 
TLX5  1 X  107 cells  LS178Y  0 
August rat leukemia  107 peripheral blood cells  1,5178Y  0 
* Cell mixture 100 thymus cells +  100 nonimmune bone marrow ceils: one target lymphoma 
cell. 
TABLE  III 
Effect  of  Varying  the  Ratio  of  Thymus  to  Bone-Marrow  Cells on  Growth Inhibition  of  the 
Target Cells 
Number of 
Immune thymocytes per 
LS178Y  cell 
Nonimmune bone-marrow  cells 
per LS178Y cell 
Growth inhibition of L5178Y 
cells at 72 hr 
25*  100  17 
50*  100  31 
75*  I00  73 
100  100  80 
150  50  56 
* To maintain the ratio of lymphoid to LS178Y cells constant at 200:1,  thymocytes from 
nonlmmune  animals were added at ratios of 75, 50, and 25:1, respectively. 
but remaining detectable for periods of up to 4 months. Fig. 1 shows the time 
sequence for the appearance of cells in the thymus which  are cytotoxic when 
mixed  in  vitro  with  bone-marrow  or  spleen  cells from  nonimmune  animals. 
This pattern resembles that observed for the appearance of the radiosensitive 
cytotoxic cells of the spleen cells from immune mice. 
Further evidence was sought for changes in the cells of the thymus of C57BL 
mice  after  intraperitoneal  injection  of  an  immunizing  dose  of  L5178Y  cells. 
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active thymidine into the DNA of thymus cells was decreased after transplanta- 
tion of tumor. Fig. 1 shows that after injection of the L5178Y cells there was a 
transient  fall  in  the  incorporation  of  thymidine by the  cells  in  the  thymus 
but that this level returns to normal at about 7 days. At this time the thymo- 
cytes become capable of causing growth inhibition in conjunction with normal 
bone-marrow cells.  The  drop  in  thymidine incorporation was unlikely  to be 
due to the stress involved in the injection for the results  were compared with a 
control  group  of  mice  that  had  been  injected  intraperitoneally  with  saline. 
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FIO. 1.  Appearance after immunization of immunologically  active thymocytes  and I)NA- 
synthesizing cells.  (©--O),  Per cent thymidine-3H  incorporation per 106 thymocytes (com- 
pared to control thymocytes from animals injected with saline).  (O---  •), Per cent growth 
inhibition after  72  hr  culture  by mixtures  of  thymocytes from  immune mice and  normal 
bone-marrow cells. 
Attempt to Assay Cytotoxicity  by Chromium-Labeled  Target Cells. In the  ex- 
periments described so far the recorded effect  was the  inhibition of growth of 
lymphoma cells  after 3 days of culture.  These lymphoma cells  were found to 
be of similar size to some of the cells present in the bone marrow, and it was 
therefore not possible to determine the fate of the lymphoma ceils within the 
first  36  hr  or  so  of  contact with  immune  thymocytes and  nonimmune bone 
marrow by the  phase-contrast  counting  technique.  After  this  time  death  of 
the lymphoid cells  and dilution of the culture facilitated accurate cell  counts 
of surviving tumor cells. To test if the cooperative growth-inhibition effect was 
due to lysis of the target cells occurring during the first 24 hr, as was found the 
case when the effector cells were spleen  cells from immune mice (6), or whether 156  TI~YMOCYTES  RENDER  BONE-~IARROW  CELLS  CYTOTOXIC 
it  was merely an inhibition  of cell  division  (cytostasis),  the  release  of radio- 
active chromimn from labeled lymphoma cells in the presence of lymphoid cell 
mixtures  was  studied.  As  we  had  found  earlier  (6),  approximately  50%  of 
5tCr was released  spontaneously within 24 hr. During this period there was no 
detectable  increase  in  free  chromium  in  any  cultures  when  the  mixture  of 
imnmne,  or  control  nonimmune  thymocytes  and  nonimmune  bone-marrow 
cells  was  added.  To  eliminate  the  possibility  that  there  was  a  latent  period 
during  which  the  cooperating  thymocytes  and  bone-marrow  cells  had  to 
interact  before  acquiring  the  capacity  for  cell  lysis,  5tCr-labeled  lymphoma 
TABLE IV 
Egect  of Agitation,  Complement,  and  Anti-Mouse-T-Globulin  Serum 
Immune thymocytes +  normal bone-marrow cells incubated with  Per cent growth inhibition 
of L5178¥  cells at 72 hr 
No agitation  80  4-  8 
Agitation after initial  18 hr*  62 
"  for 72 hr  0 
Agitation after  18 hr +  complement:~  59 
"  for 72 hr +  "  0 
No agitation  +  normal rabbit serum 
....  +  rabbit anti-mouse-T-globulin serum§ 
814-4 
794-6 
* Agitation by means of a rotary blood cell separator at 30 rpm. 
:~ Normal  rabbit serum preadsorbed with packed L5178¥ cells final concentration 10%. 
§ Final concentration  10%. 
cells were added at periods between 12 and 72 hr to a culture of immune thymo- 
cytes, nonimmune bone-marrow cells, and nonlabeled L5178Y cells. In no case 
was any increased release of 51Cr observed. These experiments indicate that the 
mechanism  of growth  inhibition  by the mixture  of immune  thymocytes and 
normal bone-marrow cells differs from that of immune spleen cells as cell lysis 
could  not  be  demonstrated.  We  cannot  distinguish  between  the  possibility 
that  the  primary  lesion  responsible  for  growth  inhibition  is  a  lyric process 
which requires more than 24 hr of culture,  or alternatively,  that the effect re- 
sults from an inhibition of division. 
Requirement for Cell-to-Cell  Contact.--The  growth inhibition of L5178Y cells 
obtained  by  the  standard  procedure  of  stationary  incubation  with  immune 
thymocytes and normal bone-marrow cells  was lost if the cells were agitated. 
Table IV shows that with constant agitation at 30 rpm on a  rotary blood cell 
separator at 37°C there was no growth inhibition; however, if the mixed culture 
was  left  stationary  for  18  hr  and  then  agitated,  growth  inhibition  occurred. C.  K.  GRANT~  G.  A.  CURRIE~  AND  P.  ALEXANDER  157 
To test if contact between cells was required for the local production of anti- 
lymphorna antibody and/or complement in sufficiently high concentrations to 
affect  cell  growth,  active  complement  (as  rabbit  serum)  or  anti-mouse--/- 
globulin serum was added to the cultures at a dilution of 1 : 10. These sera were 
adsorbed  to  remove  "anti-mouse  activity"  as  described  in  Materials  and 
Methods. The results in Table IV show that neither the addition of complement 
nor anti-globulin sera influenced the synergistic effect obtained with immune 
TABLE V 
Radiosensitivity  of  Thymocytes  and  Normal  Bone  Marrow  in  the  Synergistic  Cytotoxic  Test 
Cells tested for cytotoxicity*  Per cent growth 
Immune thymocytes  Normal hone marrow  inhibition at 72 hr 
Not irradiated  Not irradiated  80  4-  8 
"  "  200 R  76  4-  6 
"  "  1000 R  60  4-  3 
"  "  2000 R  42  4-  6 
"  "  5000 R  0 
200 R  Not irradiated  32  4-  5 
400 R  "  "  0 
Thymocytes cultured for 24 hr~: 
(a) Without L5178Y 
No irradiation  Not irradiated  54  -h  5 
200 R  "  "  10  4-  4 
(b)  With L5178Y 
No irradiation  Not irradiated  67  4-  3 
200 R  "  "  65  4-  4 
1000 R  "  "  49  4-  2 
* Final cell suspension contained  100 thymocytes  +  100 normal bone-marrow cells:one 
lymphoma cell. 
~: Thymocytes incubated for  24 hr in the presence or absence of irradiated  L5178Y cells. 
The thymocytes were then washed by centrifugation and the cells irradiated.  Subsequently 
they were added to a normal bone marrow and fresh L5178Y cell mixture. 
thymus cells  and normal bone-marrow cells.  These  results indicate that  al- 
though cell-to-cell contact was required to inhibit the growth of lymphoma cells 
in vitro, complement and antibody of the immunoglobulin classes present in 
mouse serum (see preparation of  antiserum in Materials and Methods)  were 
not involved. 
Radiosensitivity  of  the  Thymocytes  and  Bone-Marrow  Cells.--Thymocytes 
and  bone-marrow cell  suspensions were  each  exposed  separately to  doses  of 
X-rays as shown in Table V. After irradiation the suspensions were mixed at a 
ratio of  100 thymocytes +  100 bone-marrow cells to one lymphoma cell and 
the cultures assayed 72 hr later for cytotoxic activity. While the thymus cells 158  TItYMOCYTES  RENDER  BONE-M~RROW  CELLS  CYTOTOXIC 
were extremely radiosensitive, a  dose of 400 R  X-rays was sufficient to ablate 
the cytotoxic activity, bone-marrow cells were found to be more radioresistant, 
and  2000  R  was required  to  reduce  the  cytotoxicity of the  system by 50%. 
Change in  Radiosensitivity  of Thymocytes.--The  cytotoxic  action  of spleen 
cells from mice immunized 21  days previously with LS178Y was found to be 
very' radiosensitive, but if these immune spleen cells were exposed to the anti- 
gen, they transformed into radioresistant cytotoxic cells (6). A similar change 
occurred with  the radiosensitive immune th)~nocytes  (see Table V). The im- 
mune thymocytes were cultured  with specific antigen  (i.e. L5178Y cells)  pre- 
viously rendered incapable of division by exposure to 5000  R  X-rays) for 24 
hr, centrifuged, washed, and resuspended before irradiation with X-rays. After 
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FIG. 2.  Increase in RNA synthesis in thymocytes from mice immunized with L5178Y 
cells after  confrontation with irradiated  L5178Y cells: (O--O),  immune thymocytes  -I- 
L5178¥" cells; (O--O), immune thymocytes. Results expressed relative to uridine incorpora- 
tion by nonimmune thymocytes cultured with or without L5178Y cells, respectively. 
irradiation  fresh  bone-marrow  and  live  L5178¥  cells  were  added  and  the 
mixture assayed for cytotoxic activity 72 hr later. The results in Table V show 
that the thymus cells cultured without antigen and then irradiated with 200 R 
X-rays lost their cytotoxic potential but cells cultured in the presence of anti- 
gen did not. Further,  the majority of the activity was retained after a dose of 
1000 R  X-rays. 
Increase in RNA Synthesis of Immune Thymocyles in Contact with Antigen.- 
In view of the increase of radioresistance of immune thymocytes after culture 
with  irradiated  lymphoma cells,  the  effect of culturing  with  irradiated  lym- 
phoma cells on RNA  synthesis in immune thymocytes was studied  (see Fig. 
2).  To  reduce  synthesis  of nucleic  acids  by  the  lymphoma cells,  these  cells 
were  irradiated  with  5000  R  of X-rays 24  hr  earlier.  This  dose  reduced  the 
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times the mixed cell cultures were pulsed for 1 hr with tritiated uridine and the 
incorporation into acid-insoluble material was determined. The results in Fig. 
2  show  that  thymocytes from immunized  mice  in  the  presence  of  antigen 
incorporate uridine at an increased rate after the first 20 hr. 
Release  of an  Immunologically  Specific  Active  Factor from Immune  Thymo- 
cytes  in  Presence  of Antigen.--The  finding  that  RNA  synthesis  in  immune 
thymocytes was stimulated  on coming into contact with  specific antigen  and 
that the cytotoxic potential of the thymocytes became radioresistant, suggested 
that  the growth inhibition  by immune thymocytes and normal bone-marrow 
cells  occurred  in  several  stages.  The first  and  radiosensitive  phase  probably 
involved stimulation of the immune thymocytes by the specific antigen  after 
which the cells become radioresistant. To test if after contact with antigen the 
TABLE VI 
Capacity of Supernatants from  Cultures  qf C57BL Thymocytes Incubated with Irradiated 
Lymphoma Cells to Render Normal Bone-Marrow Cells Specifically Cytolox~c 
Thymocytes from  Irradiated lymphoma  Incubation period 
present 
Per cent growth inhibition  at 72 
hr produced  by normal bone- 
marrow cells plus 
Incubated  Supernatant from 
thyrnocytes  thymocyte culture 
br 
Immune  None  24  60  0 
Immune  LSI78Y  24  66  24 
.  u  48  12  57 
Nonimmune  LS178Y  48  0  0 
Immune  TLX9  48  0  0 
thymocytes produced an active factor which interacted with the bone-marrow 
cell, the supernatant from cultures containing immune thymocytes and antigen 
were tested for the capacity to render bone-marrow cells cytotoxic. Thymocytes 
were incubated for 24 and 48 hr with irradiated L5178Y cells at a ratio of 100:1. 
The  supernatant  (removed  by  centrifugation  and  passed  through  a  0.45  /z 
Millipore filter) was added to nonimmune bone-marrow cells, and the capacity 
of the bone-marrow suspensions to inhibit the growth of the lymphoma cells 
assessed. Table VI shows that ceil-free supernatants from immune thymocytes 
and antigen rendered the bone-marrow cells cytotoxic but that similar super- 
natant from nonimmune thymocytes and antigen or from immune thymocytes 
alone was quite ineffective. Thymocytes cultured  for 24 hr had produced  an 
active supernatant  and yet the  cells were still  active when  added  to  normal 
bone-marrow cells; cells incubated for 48 hr were inactive. The release of the 
soluble factor was found  to be immunologically specific because thymocytes 
from mice immunized with LS178Y cells did not give an active supernatant on 
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Nature  of  the  "Cooperating"  Cells.--To  test  the  hypothesis  that  the  cells 
in  the  bone  marrow  which  are  rendered  specifically  cytotoxic  by  immune 
thymocytes  belong  to  the  monocyte-macrophage  series,  the  normal  bone- 
marrow cells were  pretreated by culturing  with  either glass beads to remove 
glass  adherent  ceils  or  anti-macropbage  serum.  After  treatment  the  viable 
cells were assayed by exclusion  of 0.10%  trypan blue and cell  concentrations 
were corrected  to the ratios  described  elsewhere.  Table VH shows after glass 
bead treatment which removes approximately 20-30 % of all  the bone-marrow 
cells,  these  were no longer cytotoxic in  the presence  of immune thymocytes. 
On  the  other  hand,  incubation  of the  immune  tbymocytes with  glass beads 
did not reduce their capacity  to cause cytotoxicity in conjunction with normal 
bone-nlarrow cells.  Rabbit  anti-mouse macrophage serum was adsorbed with 
lymphoma  cells,  heat  inactivated,  and  subsequent  treatment  of  thymocyte 
TABLE VII 
E~ect  on  Cytotoxicity of Immune  Thymocytes +  Bone-Marrow Cells after Incubation with 
Glass Beads or Anti-Macrophage Serum 
Treatment of*  Per cent growth 
inhibition at 
Immune thymocytes  Nonlmmune bone-marrow ceils  72 hr 
None  None  69 
Glass beads  None  62 
None  Glass beads  7 
Anti-macrophage serum  None  63 
None  Anti-macrophage serum  13 
* Incubation of cells with glass beads or 10cfc anti-macrophage serum as described. 
and bone-marrow cell suspensions  (in the presence of complement for 30 rain) 
resulted in  the death  of  <5 %  of  the  thymocyte suspensions and  35-50%  of 
the  bone-marrow cell  suspensions.  Pretreatment  of  the  tbymocytes did  not 
prevent  cytotoxic activity whereas bone-marrow  cells pretreated in  a  similar 
manner were inactivated. 
DISCUSSION 
The  effector mechanisms  in  allograft  immunity  are  varied  and  complex. 
In immune mice both  circulating  antibody and  two classes of directly cyto- 
toxic lymphocytes have been  demonstrated (6). Evidence is now accumulating 
(7, 8) for a third type of lymphoid cell which has the capacity to render mono- 
cytes and/or macrophages specifically cytotoxic but by itself has no effect on 
the target cells. 
Soon  after immunization  cytotoxic  cells having  the  characteristics  of im- 
munoblasts can be found in blood, lymph, and  the draining node (or spleen). 
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cation of the  antigen.  Free or cell-bound immunoglobulins have been impli- 
cated in their activity (16, 17). A second population of cytotoxic lymphoid cells 
is found for long  periods  after immunization in  nodes  and  spleen  but  to  a 
much lesser extent in the circulation. These cells have some properties associ- 
ated with memory cells and it appears that before they acquire the capacity to 
kill  target  cells,  they  undergo  a  biochemical  (and  possibly  morphological) 
transformation in response to contact with the antigen, which results in their 
becoming in some respect like immunoblasts.  Cells taken from the thymus of 
suitably immunized mice do not contain these directly cytotoxic lymphoid cell 
types, but as has been shown here they may still be involved in the effector arm 
of  the  immune  response.  Unexpectedly  these  thymocytes  confer  cytotoxic 
properties onto normal bone-marrow or spleen cells.  The cooperative effect of 
immune  thymocytes is  abrogated by 400  R  or X-rays,  whereas  the  normal 
bone-marrow cells in the cytotoxic mixture are resistant to 1000 R. Incubation 
in the presence of lymphoma cells for 24 hr causes them to become less radio- 
sensitive and results in increased RNA synthesis. Hence some form of trans- 
formation  is  induced  in  the  thymocytes by  contact  with  antigen.  The  co- 
operative cytotoxic effect requires intimate cell-to-cell contact between immune 
thymocytes and the cooperating cell as was shown by agitation of the cultures. 
However,  when  the  immune  thymus  cells  are  transformed by contact  with 
antigen,  the  decrease in  radiosensitivity and  increasing  RNA  synthesis  are 
accompanied  by  the  release  of  a  supernatant  factor  capable  of  conferring 
cytotoxic properties onto normal  bone-marrow cells.  The supernatant  alone 
was not cytotoxic either with or without additional complement which would 
indicate that the factor is not a cytotoxic antibody. Furthermore, the addition 
of rabbit anti-mouse-'y-globulin serum did not inhibit cooperative cytotoxicity. 
Cells from the bone marrow lose their capacity to cooperate with immune 
thymocytes after  incubation  with  glass  beads  and  anti-macrophage  serum, 
and it is therefore likely  that they  are  of the monocyte-macrophage  series. 
The suggestion that immune thymocytes release a factor cytophilic for macro- 
phages is in accord with other studies in which peritoneal macrophages were 
rendered specifically cytotoxic both by contact with immune lymphoid cells 
and by supernatants  from immune lymphoid cells cultured with  the specific 
target cells (8). The release of this putative macrophage arming factor occurs 
when lymphoid cells from immune animals are exposed to the specific antigen 
and this material may be related to the migration-inhibition factor (18)  with 
the proviso that it carries the ability to recognize specific antigens. Amos and 
Lachmann (19) have demonstrated that a material causing inhibition of macro- 
phage migration forms complexes with  specific antigens.  Chemical investiga- 
tions are in progress to determine whether the material is an immunoglobulin 
or  an  immunologically specific factor having  a  different constitution. 162  THYMOCYTES  RENDER  BONE-MARROW  CELLS  CYTOTOXIC 
We consider it unlikely that  the class of immune lymphoid cells which are 
not  cytotoxic  by  themselves  but  cooperate  with  nonimmune  bone-marrow 
cells occur only in the thymus. The uniqueness of the thymus as far as effector 
cells are concerned is  that it does not contain either of the types of immune 
lymphoid cells that are directly cytotoxic and consequently the existence of a 
cell type which is only cytotoxic in cooperation with another cell can be readily 
shown.  Although  the  majority  of recirculating lymphocytes are  in  dynamic 
equilibrium  with  cells in  the  lymph  nodes  and  spleen  but  do  not  enter  the 
thymus (20, 21),  the possibility is not excluded that there may exist a  small 
subpopulation  of immune  lymphocytes that  do  pass  through  the  thymus in 
the course of recirculation. The finding that after immunization with allogeneic 
lymphoma cells in the thymus there is a phase of rapid depletion (as measured 
by thvmidine incorporation) of dividing cells which is followed by a  similarly 
rapid  recovery may be of relevance. This recovery in  the DNA  synthesis of 
cells in the thymus is accompanied by the appearance of immune cells in that 
organ. 
Finally, it must be stressed that the cell cooperation effects considered here 
refer to the process of inhibition of target cells and remain  apparently uncon- 
nected  with  cell  cooperation  between  thymus-derived  and  bone  marrow- 
derived lymphocytes which  are  involved in  the initiation  of an  immune  re- 
sponse. 
SUMMARY 
Thymocytes from  C57BL  mice  immunized  with  the  DBA/2  lymphoma 
L5178Y exert in vitro an immunologically specific cytotoxic action against the 
target cells in the presence of bone-marrow cells. Neither the nonimmune bone 
marrow nor the immune thymocytes are by themselves cytotoxic. The cells in 
the bone marrow which take part in the cytotoxic action adhere to glass and 
are  sensitive  to  anti-macrophage  serum.  These  bone-marrow  cells  can  also 
be  rendered  specifically cytotoxic by  exposure  to  the  supernatant  obtained 
from a culture of immune thymocytes with the specific target cells. The thymo- 
cytes before they are confronted with the specific  target cells are very radio- 
sensitive; however, on coming into contact with the target cells,  an  immuno- 
logically  specific  increase  in  RNA  synthesis  occurs  and  thereafter  the 
thymocytes'  capacity  to  render  bone-marrow  ceils  cytotoxic  is  relatively 
radioresistant. 
Two classes of immune lymphocytes occur in mice immunized with allogeneic 
cells,  those  that  are  capable  of killing  target  cells  directly  and  those  that 
produce a factor capable of rendering macrophages (or monocytes) specifically 
cytotoxic. In the thymus of immune animals only the latter are found while 
both categories are present in the spleen and lymph nodes of immune animals. C.  K.  (;RANT, G.  A.  CURRIE, AND  I?.  ALEXANDER  163 
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